查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1627605

骨化二醇的全球市場：預測（2025-2030）

Calcifediol Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 120 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球骨化二醇市場規模預計將以6.24%的複合年成長率成長，從2025年的19,4395萬美元達到2030年的26​​3,161萬美元。

骨化二醇，也稱為 25-羥基維生素 D3，是維生素 D 的一種，是在陽光和食物中維生素 D3 羥基化過程中在肝臟中產生的。它在腎臟中進一步羥基化形成骨化三醇，即維生素 D3 的活性形式。

骨化二醇以膠囊或液體形式給藥，可治療維生素 D 缺乏症、難治性佝僂病、遺傳性低磷血症和次發性甲狀旁腺功能低下症。它也用於治療慢性腎衰竭患者的低血鈣症和腎性骨營養不良。它與鈣結合使用可預防骨質疏鬆症。它也用於動物飼料中，透過提高牲畜和家禽的整體品質來提高維生素 D 水平和飼料轉換率。

骨化二醇的功效是膽鈣化醇的三倍，膽鈣化醇通常用於治療維生素 D 缺乏症。此外，全球維生素 D 缺乏症日益嚴重和人口老化正在推動骨化二醇補充劑的市場成長。此外，其在治療次發性副甲狀腺機能亢進、治療低血鈣和預防骨質疏鬆症的應用正在導致市場擴張。

骨化二醇市場促進因素

  • 維生素 D 缺乏的增加、微量營養素補充劑健康意識的增強將推動骨化二醇市場的成長

全球維生素 D 缺乏症患者的數量正在增加。此外，全球老年人口正在增加。包括老年人在內的人們維生素 D 缺乏症的增加，產生了對維生素 D 補充劑的需求。骨化二醇是其他維生素 D 的更好替代品，透過骨化二醇補充劑提供有效的解決方案來滿足您的維生素 D 需求。此外，年輕人的健康意識不斷增強。因此，對微量營養素的需求增加，補充維生素D的骨化二醇補充劑的需求也顯著增加。

美國國家生物技術資訊中心的一項研究表明，76.6%的參與者血清25-羥基維生素D缺乏症低於75 nmol/l，顯示維生素D缺乏症的盛行率很高。在全球範圍內，約 30-45% 的人（即約 10 億人）缺乏維生素 D。

骨化二醇市場的地域展望

  • 預計在預測期內，北美將佔據骨化二醇最大的市場佔有率

從地區來看，全球市場分為亞太地區、北美、南美、歐洲和中東/非洲。在預測期內，北美可能佔據骨化二醇的最大市場佔有率。

與其他地區相比，北美地區的人們對營養補充品越來越感興趣。由於先進的醫療基礎設施的普及以及衛生部門的重大創新和進步，預計該地區骨化二醇市場將出現成長。此外，北美的老年人口正在增加。根據美國人口普查局計劃，美國約有 7,700 萬人年齡在 65 歲及以上。因此，在預測期內，北美將主導該市場。

為什麼要購買這份報告？

  • 富有洞察力的分析：獲得涵蓋關鍵和新興地區的深入市場洞察，重點關注客戶細分、政府政策和社會經濟因素、消費者偏好、行業和其他子區隔。
  • 競爭格局：了解世界主要企業採取的策略策略，並了解透過正確的策略滲透市場的潛力。
  • 市場趨勢和促進因素：探索動態因素和關鍵市場趨勢以及它們將如何影響未來的市場發展。
  • 可行的建議：利用洞察力做出策略決策，在動態環境中釋放新的業務流和收益。
  • 受眾廣泛：對於新興企業、研究機構、顧問、中小企業和大型企業有用且具有成本效益。

它有什麼用？

產業和市場考量、機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法律規範與影響、新產品開發、競爭影響

調查範圍

  • 2022年至2030年的實際資料和預測
  • 成長機會、挑戰、供應鏈前景、法規結構、顧客行為、趨勢分析
  • 競爭定位、策略和市場佔有率分析
  • 區域收益成長和預測分析，包括細分市場和國家
  • 公司簡介（主要是策略、產品、財務資訊、主要動態等）

目錄

第1章簡介

  • 市場概況
  • 市場定義
  • 調查範圍
  • 市場區隔
  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關人員的主要利益

第2章調查方法

  • 研究設計
  • 調查過程

第3章執行摘要

  • 主要發現
  • 分析師觀點

第4章市場動態

  • 市場促進因素
  • 市場限制因素
  • 波特五力分析
  • 產業價值鏈分析

第5章骨化二醇市場：依應用分類

  • 介紹
  • 藥品
  • 動物飼料
  • 其他

第6章骨化二醇市場：依地區

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 其他
  • 中東/非洲
    • 沙烏地阿拉伯
    • 以色列
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 印尼
    • 泰國
    • 其他

第7章競爭環境及分析

  • 主要企業及策略分析
  • 市場佔有率分析
  • 併購/協議/合作
  • 競爭對手儀表板

第8章 公司簡介

  • Chemvon Biotechnolgy Co.
  • Haoyuan Chemexpress Co. Ltd.
  • BOC Science
  • Pharmaffiliates
  • DSM-Firmenich
  • Carbogen AMCIS
  • Chemicea
  • Midas Pharma
  • ApexBio Technolgy
  • OPKO Pharmaceuticals LLC
  • Nouveau Healthcare
  • Tocris Bioscience
簡介目錄
Product Code: KSI061614181

The Calcifediol Market is expected to grow at a CAGR of 6.24%, reaching a market size of US$2,631.61 million in 2030 from US$1,943.95 million in 2025.

Calcifediol is a form of Vitamin D, also known as 25-hydroxyvitamin D3, produced by the liver by the process of hydroxylation of Vitamin D3 that we get from sunlight or diet. It is further hydroxylated in the kidney to form Calcitriol, an active form of vitamin D3.

Calcifediol in capsule or liquid dosage treats vitamin D deficiency or insufficiency, refractory rickets, familial hypophosphatemia, and secondary hypoparathyroidism. It is used to treat hypocalcemia and renal osteodystrophy in patients suffering from chronic renal failure. It is used with calcium to prevent osteoporosis. It is also used in animal feed to improve its vitamin D level and feed conversation ratio by improving the overall quality of livestock and poultry.

The rising demand for calcifediol is attributed to its more advantageous features than the other forms of vitamin D. Calcifediol is 3 times more potent than cholecalciferol, commonly used to treat vitamin D deficiency. At the same time, its absorption rate is higher than that of other forms of vitamin D. Furthermore, the increasing Vitamin D deficiency worldwide, along with the aging population, is driving the market growth for calcifediol in the form of supplements. Moreover, its use in treating secondary hyperparathyroidism, managing hypocalcemia, and preventing osteoporosis is leading to market expansion.

Calcifediol Market Drivers

  • Rising Vitamin D deficiency, along with rising health awareness about micronutrient supplementation, will drive the calcifediol market growth

Globally, there is an increase in number of people with Vitamin D deficiency. The number of geriatric populations is also rising worldwide. The rising Vitamin D deficiency among the people, including the aged population, is creating demand for Vitamin D supplements. Calcifediol, a better alternative than other vitamin D, provides an effective solution to meet the demand for vitamin D in calcifediol supplements. Additionally, there is increasing health awareness among youth for their health and wellness. This has led to increased demand for micronutrients, resulting in a significant rise in the need for calcifediol supplements for vitamin D supplementation.

As per a study by the National Center of Biotechnology Information, 76.6% of participants had serum 25-hydroxyvitamin D deficiency below 75 nmol/l, showing a higher prevalence of deficiency of vitamin D. Globally, approx. 30-45% of people have vitamin D deficiency, making it around 1 billion.

Calcifediol Market geographical outlook

  • North America would be the largest market shareholder for calcifediol in the forecast period.

Region-wise, the global market is segmented into Asia-Pacific, North America, South America, Europe, Middle East and Africa. In the forecast period, North America would hold the largest market share for Calcifediol.

There are increasing trends among people in North America, compared to other regions, for dietary supplements. With the prevalence of advanced healthcare infrastructure and significant innovations and advancement in the health sector, this region is poised for growth in the Calcifediol market. Additionally, North America is experiencing a demographic shift towards the older population. In the United States of America, there would be around 77 million people aged above 65 as per U.S. Census Bureau Project. Hence, North America will dominate this market in the forecast period.

Reasons for buying this report:-

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub- segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data & forecasts from 2022 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

The Calcifediol market is analyzed into the following segments:

By Application

  • Pharmaceuticals
  • Animal Feed
  • Others

By Geography

  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • Israel
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key Benefits for the Stakeholders

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Process

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings
  • 3.2. Analyst View

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Supplier
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. The Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. CALCIFEDIOL MARKET BY APPLICATION

  • 5.1. Introduction
  • 5.2. Pharmaceuticals
  • 5.3. Animal Feed
  • 5.4. Others

6. CALCIFEDIOL MARKET BY GEOGRAPHY

  • 6.1. Introduction
  • 6.2. North America
    • 6.2.1. United States
    • 6.2.2. Canada
    • 6.2.3. Mexico
  • 6.3. South America
    • 6.3.1. Brazil
    • 6.3.2. Argentina
    • 6.3.3. Others
  • 6.4. Europe
    • 6.4.1. UK
    • 6.4.2. Germany
    • 6.4.3. France
    • 6.4.4. Italy
    • 6.4.5. Others
  • 6.5. Middle East and Africa
    • 6.5.1. Saudi Arabia
    • 6.5.2. Israel
    • 6.5.3. Others
  • 6.6. Asia Pacific
    • 6.6.1. Japan
    • 6.6.2. China
    • 6.6.3. India
    • 6.6.4. South Korea
    • 6.6.5. Indonesia
    • 6.6.6. Thailand
    • 6.6.7. Others

7. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 7.1. Major Players and Strategy Analysis
  • 7.2. Market Share Analysis
  • 7.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 7.4. Competitive Dashboard

8. COMPANY PROFILES

  • 8.1. Chemvon Biotechnolgy Co.
  • 8.2. Haoyuan Chemexpress Co. Ltd.
  • 8.3. BOC Science
  • 8.4. Pharmaffiliates
  • 8.5. DSM-Firmenich
  • 8.6. Carbogen AMCIS
  • 8.7. Chemicea
  • 8.8. Midas Pharma
  • 8.9. ApexBio Technolgy
  • 8.10. OPKO Pharmaceuticals LLC
  • 8.11. Nouveau Healthcare
  • 8.12. Tocris Bioscience